Entity Details

Primary name HSD17B3
Entity type gene
Source Source Link

Details

PrimaryID3293
RefseqGeneNG_008157
SymbolHSD17B3
Namehydroxysteroid 17-beta dehydrogenase 3
Chromosome9
Location9q22.32
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1998-08-27
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsDHB3_HUMAN

GO terms

Show/Hide Table
GOName
GO:0005783 endoplasmic reticulum
GO:0005789 endoplasmic reticulum membrane
GO:0006694 steroid biosynthetic process
GO:0006702 androgen biosynthetic process
GO:0030539 male genitalia development
GO:0043231 intracellular membrane-bounded organelle
GO:0047045 testosterone 17-beta-dehydrogenase (NADP+) activity
GO:0061370 testosterone biosynthetic process
GO:0072582 17-beta-hydroxysteroid dehydrogenase (NADP+) activity

Diseases

Show/Hide Table
Disease IDSourceNameDescription
264300 OMIMMale pseudohermaphrodism with gynecomastia (MPH)An autosomal recessive disorder that manifests, in males, as undermasculinization characterized by hypoplastic-to-normal internal genitalia (epididymis, vas deferens, seminal vesicles, and ejaculatory ducts) but female external genitalia and the absence of a prostate. This phenotype is caused by inadequate testicular synthesis of testosterone, which, in turn, results in insufficient formation of dihydrotestosterone in the anlage of the external genitalia and prostate during fetal development. At the expected time of puberty, there is a marked increase in plasma leuteinizing hormone and, consequently, in testicular secretion of androstenedione. Hence, a diagnostic hallmark of this disorder is a decreased plasma testosterone-to-androstenedione ratio. Significant amounts of the circulating androstenedione are, however, converted to testosterone, in peripheral tissues, thereby causing virilization. The disease is caused by variants affecting the gene represented in this entry.